Regulus Therapeutics Inc (NASDAQ:RGLS) Has Already Recovered 89.64%, But Another -2.37% Drop Cannot Be Ruled Out.
In recent trading session, Regulus Therapeutics Inc (NASDAQ:RGLS) saw 1.24 million shares changing hands at last check today with its beta currently measuring 0.37. Company’s